Stifel Financial Corp Ionis Pharmaceuticals Inc Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Stifel Financial Corp holds 182,505 shares of IONS stock, worth $6.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

182,505

Previous 216,140 15.56%

Holding current value

$6.55 Million

Previous $10.3 Million 29.03%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.35 Million - $1.74 Million	-33,635 Reduced 15.56%	182,505 $7.31 Million
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $959,327 - $1.26 Million	-26,319 Reduced 10.86%	216,140 $10.3 Million
Q1 2024 May 13, 2024	SELL	$42.03 - $53.55 $150,047 - $191,173	-3,570 Reduced 1.45%	242,459 $10.5 Million
Q4 2023 Feb 12, 2024	SELL	$43.39 - $51.63 $7,549 - $8,983	-174 Reduced 0.07%	246,029 $12.4 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $876,953 - $1.07 Million	-22,778 Reduced 8.47%	246,203 $11.2 Million
Q2 2023 Aug 14, 2023	SELL	$34.73 - $43.33 $29,520 - $36,830	-850 Reduced 0.32%	268,981 $11 Million
Q1 2023 May 12, 2023	BUY	$33.58 - $41.2 $2,921 - $3,584	87 Added 0.03%	269,831 $9.64 Million
Q4 2022 Feb 13, 2023	SELL	$37.12 - $46.52 $1.12 Million - $1.41 Million	-30,269 Reduced 10.09%	269,744 $10.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $230,457 - $306,898	-6,307 Reduced 2.06%	300,013 $13.3 Million
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $1.09 Million - $1.47 Million	-34,246 Reduced 10.06%	306,320 $11.3 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $519,374 - $643,829	-17,382 Reduced 4.86%	340,566 $12.6 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $467,920 - $641,312	-18,271 Reduced 4.86%	357,948 $10.9 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $49,169 - $59,446	-1,466 Reduced 0.39%	376,219 $12.6 Million
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $93,707 - $128,189	-2,713 Reduced 0.71%	377,685 $15.1 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $686,791 - $1.03 Million	16,156 Added 4.44%	380,398 $17.1 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $138,799 - $184,667	3,064 Added 0.85%	364,242 $20.6 Million
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $626,292 - $830,877	-13,199 Reduced 3.53%	361,178 $17.1 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $764,545 - $996,274	-16,319 Reduced 4.18%	374,377 $22.1 Million
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $38,147 - $58,137	917 Added 0.24%	390,696 $18.5 Million
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $913,296 - $1.11 Million	-16,960 Reduced 4.17%	389,779 $23.5 Million
Q3 2019 Nov 19, 2019	BUY	$59.06 - $72.15 $58,823 - $71,861	996 Added 0.25%	406,739 $24.4 Million
Q3 2019 Nov 13, 2019	SELL	$59.06 - $72.15 $1.09 Million - $1.33 Million	-18,418 Reduced 4.34%	405,743 $24.3 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $2.9 Million - $4.03 Million	-46,738 Reduced 9.93%	424,161 $27.3 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $6.09 Million - $9.33 Million	-115,001 Reduced 19.63%	470,899 $38.2 Million
Q4 2018 Feb 13, 2019	SELL	$43.37 - $59.54 $872,907 - $1.2 Million	-20,127 Reduced 3.32%	585,900 $31.7 Million
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $792,422 - $992,376	-18,480 Reduced 2.96%	606,027 $31.3 Million
Q2 2018 Aug 14, 2018	BUY	$40.53 - $50.7 $638,104 - $798,220	15,744 Added 2.59%	624,507 $26.1 Million
Q1 2018 May 11, 2018	SELL	$44.08 - $55.05 $35,087 - $43,819	-796 Reduced 0.13%	608,763 $26.8 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $170,667 - $218,475	-3,393 Reduced 0.55%	609,559 $30.7 Million
Q3 2017 Nov 13, 2017	BUY	$45.56 - $59.57 $27.9 Million - $36.5 Million	612,952	612,952 $0

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Ionis Pharmaceuticals Inc Transaction History